UnitedHealth Group Stock Holds Steady Near $400 Amid Q2 Earnings Beat
UnitedHealth Group's stock price has remained steady near $400 per share on the New York Stock Exchange as of September 2, 2026. The company's latest quarterly earnings beat analysts' expectations, with adjusted earnings per share coming in at $6.38, exceeding consensus estimates by $1.44 or roughly 29 percent.
The revenue for Q2 2026 was $112.03 billion, slightly higher than the expected $110.81 billion. While this represents a modest increase of about 0.4 percent compared to the same quarter in the prior year, it indicates resilient top-line growth.
UnitedHealth Group's fiscal year 2026 guidance for adjusted earnings per share is set between $19.50 and $20.00, with the midpoint at $19.75. Based on this figure, the stock's valuation stands near 20 times, a level often associated with companies that have predictable earnings and strong cash generation.
MarketBeat data shows that analysts forecast an average adjusted earnings per share of about $19.82 for UnitedHealth Group in 2026, aligning closely with management's guidance range. The consensus rating is Moderate Buy, with an average analyst price target around $456.56 per share, suggesting upside potential over the coming 12 months.